Skip to main content
logo
Faeth Therapeutics, Inc. (FTH)
NASDAQ: FTH · Real-Time Price · USD
24.43
-2.91 (-10.64%)
Aug 4, 2026, 12:48 PM EDT - Market open

Faeth Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
63013121746178
Market Cap Growth
4739.34%9.12%-28.77%-62.22%-74.18%-
Enterprise Value
415.9-6.21-25.15-42.23-53.2432.27
Last Close Price
24.4310.679.8013.8429.80116.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
-0.720.320.270.441.21
P/TBV Ratio
3.650.720.320.300.441.10

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/EBITDA Ratio
-0.280.781.161.07-
EV/EBIT Ratio
-0.280.771.141.06-
EV/FCF Ratio
-0.301.011.311.35-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.000.040.060.060.01
Net Debt / Equity Ratio
-1.07-1.06-0.98-0.92-0.96-0.99
Net Debt / EBITDA Ratio
0.940.891.171.632.003.95
Net Debt / FCF Ratio
5.490.961.511.852.524.50
Quick Ratio
19.464.987.5911.6511.8230.19
Current Ratio
19.695.067.7011.9211.9830.38
Return on Equity (ROE)
-204.16%-74.01%-58.40%-40.52%-38.88%-81.70%
Return on Assets (ROA)
-187.38%-65.30%-54.48%-38.46%-36.96%-42.92%
Return on Invested Capital (ROIC)
-9734.15%-518.63%-425.96%-345.10%-580.88%-1111.07%
Return on Capital Employed (ROCE)
-200.45%-76.11%-60.04%-41.64%-38.96%-45.45%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-0.96%-0.40%10.15%8.96%-10.80%-1618.88%
Total Shareholder Return
-0.96%-0.40%10.15%8.96%-10.80%-1618.88%
SEC Filings: 10-K · 10-Q